...
机译:发现癌细胞选择性双作用抗癌剂(Z)-2-(1 H-吲哚-3-基)-3-(异喹啉-5-基)丙烯腈(A131)
Department of Pharmacy National University of Singapore;
Program in Cancer &
Stem Cell Biology Duke-NUS Medical School;
Program in Cancer &
Stem Cell Biology Duke-NUS Medical School;
Program in Cancer &
Stem Cell Biology Duke-NUS Medical School;
Program in Cancer &
Stem Cell Biology Duke-NUS Medical School;
Program in Cancer &
Stem Cell Biology Duke-NUS Medical School;
Department of Pharmacy National University of Singapore;
Antitumor; Antimitotic; Antiproliferative; Tumor-selective;
机译:发现癌细胞选择性双作用抗癌剂(Z)-2-(1 H-吲哚-3-基)-3-(异喹啉-5-基)丙烯腈(A131)
机译:血管破坏剂2-(3'-羟基-4'-甲氧基苯基)-3-(3“,4”,5“-三甲氧基苯甲酰基)-6-激发的吲哚类抗癌药的合成和生物学评估甲氧基吲哚(OXi8006)
机译:N-(2-(2-(2-(2-(2-羟基乙氧基)-6morpholinyinyInyIn-4-基-4-甲基苯基)-2-(三氟甲基)异洛氨基酰胺,选择性,有效,耐受良好的RAF抑制剂靶向RAS的设计和发现 突变癌:诊所的道路
机译:对HeLa细胞系抗癌剂(PBE)对猪孢子提取物(PBE)的体外评价 - 初步研究
机译:抗癌治疗剂预测癌突变和自主药物发现的综合机学习和数据科学方法
机译:血管破坏剂2-(3-羟基-4-甲氧基苯基)-3-(345-三甲氧基苯甲酰基)-6-激发的吲哚类抗癌药的合成和生物学评估甲氧基吲哚(OXi8006)
机译:胆固醇相互作用剂甲基-β-环糊精和ostreolysin A / pleurotolysin B蛋白复合物对尿路上皮癌细胞的高选择性抗癌活性